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Monash University, Clayton, Victoria, AustraliaABSTRACT The role of proline in the disruption of membrane bilayer structure upon antimicrobial peptide (AMP) binding was
studied. Specifically, 31P and 2H solid-state NMR and dual polarization interferometry (DPI) were used to analyze the membrane
interactions of three AMPs: maculatin 1.1 and two analogs in which Pro-15 is replaced by Gly and Ala. For NMR, deuterated
dimyristoylphosphatidylcholine (d54-DMPC) and d54-DMPC/dimyristoylphosphatidylglycerol (DMPG) were used to mimic
eukaryotic and prokaryotic membranes, respectively. In fluid-phase DMPC bilayer systems, the peptides interacted primarily
with the bilayer surface, with the native peptide having the strongest interaction. In the mixed DMPC/DMPG bilayers, maculatin
1.1 induced DMPG phase separation, whereas the analogs promoted the formation of isotropic and lipid-enriched phases with
an enhanced effect relative to the neutral DMPC bilayers. In gel-phase DMPC vesicles, the native peptide disrupted the bilayer
via a surface mechanism, and the effect of the analogs was similar to that observed in the fluid phase. Real-time changes in
bilayer order were examined via DPI, with changes in bilayer birefringence analyzed as a function of the peptide mass bound
to the bilayer. Although all three peptides decreased the bilayer order as a function of bound concentration, maculatin 1.1 caused
the largest change in bilayer structure. The NMR data indicate that maculatin 1.1 binds predominantly at the surface regions of
the bilayer, and both NMR and DPI results indicate that this binding leads to a drop in bilayer order. Overall, the results demon-
strate that the proline at residue 15 plays a central role in the membrane interaction of maculatin 1.1 by inducing a significant
change in membrane order and affecting the ability of the bilayer to recover from structural changes induced by the binding
and insertion of the peptide.INTRODUCTIONStudies examining the mechanism of antimicrobial peptide
(AMP) action seek to define the structure of the final
membrane disruption entity. Although this provides very
important information in terms of the mechanism of disrup-
tion, there is still limited capacity to rationalize differences
in the activity of closely related peptides. To provide
a more detailed description of membrane binding and
disruption, more specific information is required regarding
the molecular changes that occur in the membrane bilayer
from the point of first interaction to the final dissociation
from, or disruption of, the membrane. This process includes
multiple steps associated with changes in the peptide and
membrane structure and the insertion/reorientation of the
peptide, and characterization of these steps would clearly
allow a more detailed definition of peptide-membrane
interactions.
Maculatin 1.1 (GLFGVLAKVAAHVVPAIAEHF-NH2)
is a cationic AMP that is isolated from the skin secretions
of the frog species Litoria genimaculata (1) and possesses
antibacterial (1–6), antitumour (7), and antiviral (8) activity.
Studies have shown that maculatin 1.1 interacts with model
membranes composed of zwitterionic dimyristoylphospha-
tidylcholine (DMPC) and mixed DMPC/dimyristoylphos-Submitted December 6, 2012, and accepted for publication January 28,
2013.
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0006-3495/13/04/1495/13 $2.00phatidylglycerol (DMPG) bilayers, with a greater effect on
anionic membranes (5,9–12). Replacement of the Pro-15
residue results in a rearrangement into a tighter, more
canonical a-helix with altered hydrophobicity and antimi-
crobial activity (13). These and other studies conducted on
related families (2) indicate that maculatin 1.1 may exert
its mode of action through a pore-formation mechanism
(3,10,14–16).
As the peptide binds and reorients either partially or fully
into the membrane interior, the phospholipid molecules also
undergo a structural reorganization, and these changes in
bilayer structure are integral to the process. Because biolog-
ical membranes vary in composition among species, model
membranes are used to define specific properties, such as the
charge characteristics, of eukaryotic and prokaryotic
membranes. Phosphatidylcholine lipids are common within
eukaryotic organisms (17,18), whereas, despite variations
among species, bacterial membranes tend to contain lipids
with anionic headgroups that are effectively mimicked by
the use of phosphatidylglycerol. For many systems, the
specific lipid phase chosen also modulates peptide-
membrane interactions. Previous AMP studies typically
used fluid-phase (La) lipid membranes, but certain AMPs,
such as magainin 2 and the membrane-lytic peptide melittin,
have been shown to have enhanced interactions with
gel-phase lipid systems (19–25). Similarly, quartz crystal
microbalance-dissipation (16) and dual polarization inter-
ferometry (DPI) (26) studies of several frog AMPs,http://dx.doi.org/10.1016/j.bpj.2013.01.059
1496 Fernandez et al.including aurein 1.2 and maculatin 1.1 (16,26), showed
stronger interactions in supported lipid bilayers (SLBs)
below the gel-fluid transition temperature.
A feature of many AMPs is the presence of a proline
residue, which has a significant effect on the peptide struc-
ture and biological activity. However, how the proline
residue exerts its effect on biological activity in terms of
membrane structure is not clear. Solid-state NMR is a power-
ful tool for studying the effect of peptides on phospholipid
bilayer structure and characterizing the membrane-binding
properties of a range of peptides (5,13,15,19,24,27–32).
Recently, we described the application of DPI to the analysis
of membrane bilayer structure in terms of changes in bire-
fringence (26,33–35), which provided apparently new
insight into molecular events throughout the peptide-
binding process. In the study presented here, we used
solid-state NMR and DPI to analyze the effects of proline
substitution in the AMP maculatin 1.1 on the bilayer struc-
ture of neutral and net anionic phospholipid membranes.
Proline has a specific effect on peptide and protein structure
and flexibility (29,36–41), and the changes in membrane
structure induced by the binding of these peptides reveal
the critical role of the proline residue in the disruption of
the bilayer structure.MATERIALS AND METHODS
Preparation of NMR samples
Perdeuterated-acyl chain 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(d54-DMPC) and natural abundance 1,2-dimyristoyl-sn-glycero-3-[phos-
pho-rac-(1-glycerol)] (DMPG) were purchased from Avanti Polar Lipids
(Alabaster, AL) and used without further purification. Maculatin 1.1, mac-
ulatin P15G, and maculatin P15A were obtained from Mimotopes
(Melbourne, Australia) with a purity of >90%. HCl solution was added
before each peptide was lyophilized (42) to ensure that any traces of tri-
fluoroacetic acid were removed.
Lipid films were prepared from d54-DMPC or d54-DMPC/DMPG (2:1
molar ratio) dissolved in CHCl3/MeOH. Dried lipid thin films typically
were hydrated with 500 mL of Milli-Q water before being lyophilized.
The dried samples typically were rehydrated with 100 mL of 10 mM
MOPS (3-(N-morpholino) propanesulfonic acid) buffer (pH 7) or peptide
solubilized in MOPS buffer to a 10:1 lipid/peptide (L/P) molar ratio and
subjected to five cycles of freeze-thaw before being transferred into NMR
rotors or 5 mm NMR glass sample tubes. Typically 1 mg of peptide and
4 mg of phospholipid were used.Solid-state NMR experiments
Static deuterium spectra were obtained at 46.1 MHz on a Varian Inova-300
spectrometer (Palo Alto, CA) using a composite-pulse solid-echo sequence.
Operating conditions included 4.1 ms 90 pulses, 40 ms echo delay, and 0.5 s
recycle time. Typically a minimum of 20,000 scans were collected and
Fourier transformed using zero-filling to 16,384 points with 200 Hz expo-
nential line-broadening. Oriented spectra were generated by dePaking in the
time domain using a recently developed nmrPipe macro (Dr. John Gehman,
University of Melbourne). The dePaked spectrum was fit with Gaussian
line shapes and converted to order parameters by dividing the static splitting
of each 26 myristoyl CDn position with a static coupling constant of
255 kHz (43).Biophysical Journal 104(7) 1495–150731P static solid-state NMR experiments were performed at 121.5 MHz on
a Varian Inova-300 spectrometer using a Hahn echo pulse sequence with
proton decoupling. Typically a 4.4 ms 90 pulse was used with 29 ms
echo time and 3 s recycle delay. A minimum of 20,000 scans were collected
and processed with 100 Hz exponential line-broadening and zero-filling to
8,192 points. Static 31P NMR spectra were deconvoluted as previously
described (13).
Each sample was subjected to a temperature cycle in which the static
deuterium and phosphorus spectra were acquired with the bearing air
supply set first to 30C, 20C, and 15C, and then reheated to 30C. The
NMR probe was removed from the magnetic field between each tempera-
ture change and the samples were allowed to equilibrate for a minimum
of 1 h and then replaced in the magnet for 15–20 min before spectra
were collected.Liposome preparation for DPI
Thin lipid films of DMPC and DMPC/DMPG (4:1) were hydrated to 1 mM
lipid concentration with 10 mMMOPS, 150 mM NaCl pH 7.0, buffer solu-
tion at 37C for 1 h with constant vortexing. The hydrated lipid suspension
was sonicated in a water bath for ~30 min at 37C and extruded before use
through 50 nm polycarbonate membranes (19 times) using an Avestin Lipo-
fast extruder (Ottawa, Canada).Deposition of SLBs on sensor chips
Planar SLBs were prepared via in situ adsorption of liposomes to a silicon
oxynitride waveguide sensor chip. An unmodified FB80 AnaChip (Farfield
Group, Manchester, UK) was clamped inside a dual-zone temperature-
controlled housing. The temperature was controlled to within 0.005C using
a Peltier system. A 100-mm-thick fluorosilicon gasket containing two sepa-
rate 1.7 mL microfluidic channels was clamped over the sensing waveguide.
FB80 waveguide chips were cleaned and calibrated for their optical proper-
ties as previously described (26,35). The bulk buffer solution (10 mM
MOPS, 150 mM NaCl, pH 7.0) was used as the flow media throughout
all experimental steps, and all solutions were degassed before use. Flow
rate during experiments was controlled with the use of a Harvard Apparatus
PHD2000 programmable syringe pump. For lipid bilayer formation, the
temperature of the system was set to 28C. The previously prepared lipid
stock suspension then was extruded and diluted to 0.1 mg/mL with further
MOPS buffer containing 1 mM CaCl2, which was added to promote vesicle
rupture and SLB formation (44–46).
The liposome solutions were injected for 10 min at a flow rate of
20 mL/min, and immediately afterward, further bulk buffer with 1 mM
CaCl2 was injected (200 mL at 20 mL/min) to stabilize the SLB. The ad-
sorbed bilayer was then allowed to equilibrate for 20 min under running
buffer until a stable baseline had been achieved. The temperature was
then set to either 20C or 30C depending on the experiment and allowed
to equilibrate before peptide addition.
Maculatin 1.1, maculatin P15A, and maculatin P15G were prepared at
concentrations of 1, 2, 5, 10 and 20 mM in the running buffer (10 mM
MOPS, 150 mM NaCl, pH 7.0). A fresh bilayer was used for each indi-
vidual peptide measurement and 160 mL of each concentration was in-
jected sequentially onto the SLB in increasing concentrations at a flow
rate of 40 mL/min, with a total of 30 min equilibration time between
injections.DPI
Data acquisition was carried out using AnaLight200 version 2.1.0 software
and analyzed using AnaLight Explorer proprietary software as previously
described (26,35,47). The theory of DPI has been treated more extensively
in previous papers (26,35,47–50) and a basic description is provided in the
Supporting Material.
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Peptide-lipid acyl chain interaction observed
by 2H static solid-state NMR
2H NMR analysis of acyl chain deuterated phospholipid
bilayers provides information about the acyl chain order
and interactions occurring within the membrane (51). 2H
NMR experiments were performed to determine the effects
of the maculatin analogs on the acyl chains and bilayer
structure below and above the gel- to fluid-phase transition
temperature.
DMPC (Fig. 1 a) and DMPC/DMPG bilayers gave typical
order parameter profiles (13), and inclusion of DMPG had
little effect on the DMPC acyl chain order (Figs. 1 b and
2) (13,31). The order parameters of DMPC (Fig. 1 a) with
maculatin 1.1 and P15G were reduced by ~19% and ~5%,
respectively, whereas minimal change was seen with
P15A. A 5–10% decrease in lower acyl chain order was
seen in d54-DMPC/DMPG bilayers with maculatin 1.1 and
P15A, whereas P15G had a more complex effect and the
spectra contained features of a mixed gel/fluid phase
(Figs. 1 b and 2).
At 20C, which is just below the gel-fluid transition of the
pure lipids, the spectra were characteristic of immobilized
Lb0 gel-phase lipids. Gel-phase spectra were observed for
maculatin 1.1 and P15A with DMPC (Fig. 2), with a small
isotropic peak for maculatin 1.1. Fluid-phase characteristics
with moderate broadening were observed with maculatin
P15G in DMPC. A similar spectrum was observed for the
anionic bilayer with maculatin 1.1, whereas mixed lipid
phases were observed with both maculatin analogs.At 15C, gel-phase spectra were observed for the lipid-
only samples. Maculatin 1.1 produced a broad isotropic
2H spectrum in DMPC, whereas both analogs produced
mixed gel- and isotropic-phase spectra in both types of lipid
bilayers.
Heating through the gel- to fluid-phase transition back to
30C (Fig. 1, c and d) resulted in fluid lamellar phases with
reduced order and resolution for DMPC bilayers with mac-
ulatin 1.1 and P15G. By contrast, acyl chain order increased
with P15A. In DMPC/DMPG, order uniformly decreased
slightly with maculatin 1.1 (Fig. 1 d). With P15G, we de-
tected a mixed gel/disordered fluid phase similar to that
observed before the decrease in temperature, suggesting
that the peptide stabilized lipid domains in the bilayer. For
P15A, the order parameters decreased ~10% in the upper
acyl chain regions and 1–2% in the lower regions. Thus,
a slow passage through the gel-fluid transition, as opposed
to the rapid freeze/thaw steps performed during sample
preparation, led to a greater effect of the peptide on the lipid
bilayer.Probing phospholipid headgroup dynamics
by static 31P solid-state NMR
31P NMR of phospholipid bilayers gives information on the
lipid phase, local order, and dynamics within the phosphate
region of the lipid (52). Fluid lamellar (La) phospholipid
liposomes produce an axially symmetric powder pattern
(chemical shift anisotropy (CSA)) whose overall width
depends on headgroup orientation and disorder (53). Hence,
31P NMR was used to probe peptide-induced headgroupFIGURE 1 Order parameter profile obtained
from dePaked spectra of maculatin 1.1 and analogs
in d54-DMPC (left) and d54-DMPC/DMPG (2:1)
(right) at 30C (top) and after temperature cycling
through 15C and a return to 30C (bottom). Lipid
alone (circles), lipid þ maculatin 1.1 (squares),
lipidþ P15G (stars), and lipidþ P15A (triangles).
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FIGURE 2 2H NMR spectra of d54-DMPC (left) and d54-DMPC/DMPG (2:1) (right) phospholipid bilayers with maculatin 1.1, maculatin P15G, and mac-
ulatin P15A. Spectra were recorded at 30C, 20C, and 15C, and reheated to 30C.
1498 Fernandez et al.perturbations. Multilamellar vesicles produced typical
powder patterns at 30C, with a CSA of ~45 ppm for
DMPC and overlapping 40 and 31 ppm CSA for DMPC
and DMPG, respectively, in the mixed lipid bilayer (not
shown). Maculatin 1.1 and P15A reduced the DMPC CSA
by 33% and 23%, respectively, whereas P15G had less effect
(9%; Fig. 3 and Table 1). In the mixed bilayer, the peptides
produced two clearly distinguishable CSAs, but both
analogs also led to broad isotropic signals (Fig. 3).
When cooled below its gel-fluid transition to 20C (54),
DMPC (and DMPC/DMPG) formed a mixed ordered and
disordered Pb0 ripple phase (55,56). With maculatin 1.1,
the CSA was further reduced and a larger isotropic peak
indicated additional disorder. No large changes were
observed with P15G, and P15A gave only a minor CSA
increase with a small isotropic signal. No major change in
DPMC/DMPG was seen with maculatin 1.1, but both
analogs showed a greater effect than on the neutral bilayer.Biophysical Journal 104(7) 1495–1507The isotropic signal and CSA linewidth increased with
P15A, and an additional broad CSA formed with P15G.
No significant spectral change occurred for DMPC at
15C. With maculatin 1.1, a fully isotropic spectrum formed
(Fig. 3), indicating a very significant bilayer disruption.
Formation of an immobilized lipid phase was observed
with P15A, whereas disorder increased for P15G with
a reduction in CSA and formation of a small isotropic peak.
In the anionicDMPC/DMPGsystem,maculatin 1.1 produced
a small isotropic peak. With P15A the isotropic signal was
reduced and an additional 50 ppm CSAwas formed, whereas
with P15G, both bilayer CSA componentsmoderately broad-
ened and the isotropic signal increased in proportion.
Returning to 30C yielded similar spectra for the lipid-
only spectra as observed previously, but for maculatin 1.1
with DMPC, a heavily disordered bilayer reformed. No
significant change was seen with P15A or P15G, apart
from a small fraction of signal showing an isotropic phase.
FIGURE 3 31P NMR spectra of DMPC (left) and DMPC/DMPG (2:1) (right) phospholipid bilayers with maculatin 1.1, P15G, and P15A. Spectra were
recorded at 30C, 20C, and 15C, and reheated to 30C. Unbroken lines represent the experimental spectra. Dotted lines represent deconvoluted compo-
nents.
Effect of Proline on Membrane Binding of Maculatin 1.1 1499In the mixed-lipid system, two clearly distinguished CSAs
were observed with maculatin 1.1, but, as for DMPC, each
bilayer CSA was narrower than it was initially. Maculatin
P15A broadened the CSAs and altered the proportions rela-
tive to initial values, whereas the isotropic signal decreased.
Maculatin P15G behaved similarly to maculatin 1.1: the
major CSAs were narrower than their initial values and
the isotropic signal decreased.
Overall, the NMR studies demonstrate that all three
peptides alter the bilayer structure of both membrane
systems and the bilayer disruption is significantly modu-
lated by temperature.Interaction of maculatin peptides with SLBs
We studied the membrane-binding characteristics of macu-
latin peptides and their effects on the membrane structureusing DPI on consistent and well-defined supported phos-
pholipid bilayers. The structural parameters of supported
DMPC and DMPC/DMPG (4:1 molar ratio) bilayers formed
via in situ liposome deposition and characterized by DPI are
listed in Table 2. The mass, density, thickness, and birefrin-
gence values of each bilayer are consistent with a thinner,
more disordered bilayer at 30C and a thicker bilayer with
a more orderly alignment of lipid molecules at 20C. These
values are also consistent with complete surface coverage
by unilamellar bilayers and were highly reproducible for
all binding assays.
The accumulative binding of each maculatin peptide at 1,
2, 5, 10, and 20 mM were characterized by the transverse
magnetic (TM) and transverse electric (TE) phase changes
obtained at both 30C and 20C for the fluid- and gel-state
membranes, respectively. The L/P ratios were first deter-
mined for each peptide-bilayer system at the end of theBiophysical Journal 104(7) 1495–1507
TABLE 1 Effect of maculatin 1.1 and analogs on 31P NMR CSA of DMPC and DMPC/DMPG (2:1) multilamellar vesicles
Temp
DMPC DMPC/DMPG (2:1)
Lipid bilayer Mac1.1 Mac P15G Mac P15A Lipid bilayer Mac1.1 Mac P15G Mac P15A
30C 45.5 30.4 41.6 35.2 40 (68) 41.8 (74) 43 (39.5) 34.9 (58)
31.2 (32) 26.5 (23) 27.5 (23) 24 (22)
Iso (37.5) Iso (20)
20C 56.3 (57) 26.5 (67) 40 37.4 (88.5) 41 (61.5) 39.8 (73.5) 47.3 (11) 40.1 (18)
40.4 (42) Iso (33) Iso (11.5) 27.5 (33.5) 28.9 (26.5) 27.5 (39) 25.8 (7.5)
Iso (1) Iso (5) 19.6 (21) Iso (74.5)
Iso (29)
15C 56.4 (61) Iso 35.4 (96) 49.1 (52) 47 (12) 39.1 (55.5) 36.3 (23) 49.6 (27.5)
40 (36.5) Iso (4) 38.4 (35.5) 42.5 (41.5) 22.1 (29.5) 27.9 (19) 41 (19)
Iso (2.5) Iso (12.5) 16.2 (31) Iso (15) Iso (58) 22.7 (21)
Iso (15.5) Iso (32.5)
Reheat to 30C 24.5 (57) 38.6 (96) 35.8 (95) 29.5 (78) 34.1 (56.5) 39.1 (52)
Iso (43) Iso (4) Iso (5) 17.2 (22) 17.8 (26) 25.9 (41)
Iso (17.5) Iso (7)
Numbers in parentheses indicate % contribution to signal.
Iso, isotropic peak.
1500 Fernandez et al.association phase and are listed in Table 2. The L/P values
range from 4:1 to 35:1 and reflect the variation in the
amount of peptide bound. These values also correlate with
the 1:10 L/P ratio used to prepare the samples for NMR
analysis, and confirm that the DPI experiments were per-
formed within a similar ratio.
TM and TE phase changes for each peptide binding to
DMPC and DMPC/DMPG (4:1) are shown in Fig. 4. Small
increases in TM and TE phase changes were observed at low
concentrations (<5 mM) for all three peptides binding to the
DMPC SLB, with different behavior at higher concentra-
tions (5–20 mM). Maculatin 1.1 caused large TM and TE
phase changes above 5 mM at 30C and 20C. Maculatin
P15G only showed a large phase change at 20 mM at 30CTABLE 2 DPI structural values and lipid/peptide ratios (L/P) for ma
(4:1) lipid bilayers
DPI st
Density (g/cm3) Thickness (A˚)
30C
DMPC 1.0035 0.003 45.15 0.6
PC/PG 1.0075 0.003 44.55 1.0
20C
DMPC 1.0025 0.002 47.25 0.8
PC/PG 1.0045 0.004 47.55 1.2
Peptide Concentration (mM)
30C
DMPC
Mac 1.1 5 9.4
10 7.3
20 6.6
Mac P15G 5 36
10 20.8
20 5.9
Mac P15A 5 35.5
10 5.8
20 4.1
Biophysical Journal 104(7) 1495–1507and above 5 mM at 20C, and a higher peptide concentration
was required for binding to the more-fluid SLB (30C)
compared with maculatin 1.1. Similarly, large irreversible
TM and TE phase changes were observed for the binding
of 10 mM P15A to the more-fluid DMPC (30C) or for
binding of 5 mM P15A to the gel-like DMPC (20C).
Although a higher peptide concentration was required to
generate large increases in the TM and TE phases, the
effects were larger than those observed for maculatin 1.1.
With both analogs, larger phase changes were observed in
the more-ordered DMPC at 20C.
The effect of peptide binding on a negatively charged
membrane was also investigated. The molar fraction of
DMPG was reduced to 20% for the DPI analysis, whichculatin peptides binding to supported DMPC and DMPC/DMPG
ructural values for SLBs
Mass (ng/mm2) Birefringence Area/lipid (A˚2)
4.525 0.06 0.01935 0.0007 49.95 0.7
4.485 0.11 0.02005 0.0009 50.55 1.2
4.735 0.08 0.02235 0.0003 47.65 0.82
4.775 0.1 0.02235 0.0003 47.45 1.0
L/P
20C
PC/PG (4:1) DMPC PC/PG (4:1)
24.1 10.6 9.6
11.3 9.1 9.4
11 8 9
16.6 13.2 13.5
6.6 6.5 5.6
6 5.8 4.6
51 16.3 12.2
20.6 5.5 5.4
5.4 4 4
FIGURE 4 Real-time TM and TE phase changes in radians for consecu-
tive injections of 1, 2, 5, 10, and 20 mM maculatin 1.1, P15G, and P15A
onto planar solid supported DMPC and DMPC/DMPG (4:1) bilayers at
30C and 20C.
Effect of Proline on Membrane Binding of Maculatin 1.1 1501resulted in consistent formation of well-defined bilayers
while retaining a suitably anionic surface. Similarly to the
DMPC SLB, all three peptides showed little to no binding
below 5 mM, except for P15A at 20C. Above 10 mM, mac-
ulatin 1.1 induced significant phase changes at 30C but
they were of a lower magnitude than observed with the
DMPC SLB. At 20C, large phase changes occurred above
5 mM and there was less dissociation than at 30C. At 5 mM
and above, P15G induced large TM and TE phase changes
(with a greater change at 20C) that were larger than the
phase changes caused by maculatin 1.1. By contrast, mac-
ulatin P15A bound irreversibly above 5 mM, with small
and large phase changes seen at 30C and 20C,
respectively.
The measured TM and TE phases were subsequently
resolved into the mass of membrane-bound peptide and
birefringence for both lipid bilayers. Plots of mass changes
versus time and birefringence versus time are shown in Figs.
S1 and S2. However, because both the peptide mass and the
structural changes associated with their binding to the lipid
bilayer contribute to the measured TM and TE phase
changes, analysis of changes in bilayer order as a function
of peptide mass allows the impact of peptide binding on
the membrane structure to be analyzed. The changes in
DMPC and DMPC/DMPG bilayer order induced by macu-latin 1.1 and both analogs are shown in Fig. 5, with the asso-
ciation phase indicated by the solid arrow and dissociation
indicated by the dotted arrow.
The binding of maculatin 1.1 to the more-fluid DMPC
showed a small decrease in birefringence at low peptide
mass. As maculatin 1.1 accumulated on the DMPC bilayer,
birefringence did not initially change, but it then decreased
as the membrane-bound maculatin 1.1 reached a threshold
value, as indicated by the inflection points in Fig. 5. In
comparison, P15G induced a small disordering in the
more-fluid DMPC initially with a greater level of disorder-
ing observed at high peptide mass. Such disordering was
almost reversible after the peptide dissociated from the
membrane, which resulted in a very small degree of overall
disordering in the more-fluid DMPC SLB. The binding of
P15A to DMPC at 30C induced the largest disordering
with the highest amount of bound peptide. This disordering
was irreversible at lower concentrations and only became
partially reversible at high peptide mass.
At 20C, in contrast, the binding of maculatin 1.1 and
both analogs to DMPC caused a linear decrease in bilayer
order, even at very low amounts of bound maculatin 1.1.
With the subsequent addition of peptide to the DMPC
bilayer, maculatin 1.1 induced more disorder at 20C than
in the more-fluid DMPC at 30C. The changes in the bilayer
order were irreversible up to a certain amount of peptide
bound to the membrane or a critical L/P ratio, which showed
as inflection points in the birefringence versus mass plot.
The changes in the bilayer order then became a reversible
process when more peptide bound beyond this critical L/P
ratio. Maculatin P15G also induced a large linear decrease
in bilayer order, but the change in birefringence of DMPC
at 20C was greater than that observed for maculatin 1.1.
This reversible disordering indicated that the more-fluid
bilayer at 30C recovered to the initial membrane ordering
more effectively than the lower-temperature phase. Thus,
the substitution of proline to glycine resulted in more bound
peptide and exerted a larger impact on DMPC order at 20C
than on the more-fluid DMPC at 30C. The P15A analog
showed the highest amount of binding and also induced
the largest disordering in DMPC at 20C, which only
became partially reversible at 20 mM.
The changes in the molecular order of the DMPC/
DMPG bilayers induced by the binding of maculatin
peptides at 30C and 20C are shown in Fig. 5 and show
distinct differences compared with DMPC. The binding
of maculatin 1.1 to the more-fluid DMPC/DMPG SLB at
30C resulted in small increases in bilayer order at low
levels of membrane-bound peptide. Significant bilayer
disorder was observed with subsequent increases in the
mass of maculatin 1.1 bound to DMPC/DMPG. High levels
of P15G bound to the more-fluid DMPC/DMPG, which
was associated with the induction of large decreases in
bilayer order that were only partially reversible during
the peptide dissociation. Maculatin P15A bound to theBiophysical Journal 104(7) 1495–1507
FIGURE 5 Birefringence (molecular order)
changes in supported DMPC and DMPC/DMPG
(4:1) lipid bilayers as a function of mass of
membrane bound peptide at 30C and 20C.
Changes were calculated for consecutive injections
of 1, 2, 5, 10, and 20 mMmaculatin 1.1, P15G, and
P15A. Arrowed lines indicate association (solid
line) and dissociation (dotted line) phases.
1502 Fernandez et al.more-fluid DMPC/DMPG with the largest amount and
induced a relatively greater decrease in bilayer order than
maculatin 1.1 and P15G.
At 20C, the bilayer order of DMPC/DMPG decreased
at low levels of bound maculatin 1.1 and showed a large
and sharp decrease in bilayer order when maculatin 1.1
reached a critical amount. This large, sudden disordering
was not observed with the neutral DMPC membranes.
The changes in DMPC/DMPG order at 20C induced by
P15G also showed a large sharp decrease in bilayer order
similar to that observed for maculatin 1.1. However, more
P15G was bound and induced more disordering in the
DMPC/DMPG SLB than maculatin 1.1. Maculatin P15A
gradually accumulated on DMPC/DMPG and resulted in
the largest amount of peptide bound. The disordering of
the DMPC/DMPG SLB induced by P15A was similar to
that induced by P15G and larger than that induced by
maculatin 1.1. These overall differences show that the
negative charges on the membrane surface resulted in
a greater susceptibility of the bilayer to peptide-induced
disordering.Biophysical Journal 104(7) 1495–1507DISCUSSION
The disruption of a phospholipid bilayer by AMPs is asso-
ciated with a complex series of geometrical and dynamic
changes that occur within the lipid matrix during peptide
association-dissociation, insertion, and, ultimately, disrup-
tion of membrane integrity. Maculatin 1.1 has been shown
to have significant effects on the membrane bilayer struc-
ture. We propose that the proline residue at position 15 plays
a critical role in the activity of maculatin 1.1 by facilitating
the disruption of the membrane bilayer structure. Thus, to
unravel the mechanism of action, it is crucial to characterize
the effects on the membrane structure throughout the
process of peptide binding leading to insertion. In this study,
we used NMR and DPI to investigate the effect of proline
substitution on the characteristics of maculatin 1.1 binding
to lipid bilayers composed of DMPC and DMPC/DMPG.
Specifically, the effects of replacing Pro-15 with Gly and
Ala in maculatin 1.1 on the membrane structure were inves-
tigated. To obtain further insight into peptide selectivity and
insertion mechanisms in terms of changes in membrane
Effect of Proline on Membrane Binding of Maculatin 1.1 1503structure and order, we also investigated the role of nega-
tively charged phospholipids and lipid phases, such as the
ordered/disordered Pb0 ripple phase (21,25), in modulating
the membrane-destabilization effects of the maculatin
analogs.
The NMR studies showed evidence of different
membrane structures in the presence of each peptide. In
particular, the isotropic phase was quite prevalent under
some conditions and is consistent with the formation of
a toroidal pore-like network. The ability of each peptide
to induce this structure, together with the capacity of the
membrane to recover, either through temperature changes
or after peptide dissociation, provides (to our knowledge)
new information that allows us to establish a more-detailed
mechanistic understanding of AMP action.
The large reductions in 31P CSA (Table 1) and 2H order
parameter profiles of the lipid bilayers (Fig. 1) are an indi-
cation of increased disorder promoted by peptide interac-
tion. The reduction in the acyl chain order and CSA
linewidth suggests that these peptides perturb DMPC bila-
yers, exhibiting a primarily surface interaction with fluid-
phase DMPC bilayers. The formation of visually distinct
CSA and isotropic signals, together with the coexistence
of mixed lipid phases in the anionic bilayers, indicates
that these peptides actively perturb the bilayer and may
segregate lipids and promote demixing or domain formation
(57,58). The extent of bilayer disordering as indicated by the
NMR data followed the order Mac P15G < Mac P15A <
Mac1.1 and is consistent with the intercalation of each
peptide between the lipid headgroups, which increased the
disorder and motional freedom in both headgroup and acyl
chains.
We investigated the effect of peptide binding on the
bilayer structure throughout the gel- to fluid-phase transition
by performing NMR measurements at 30C, 20C, and
15C, and reheating to 30C. Defects formed in the mixed
ordered/disordered Pb0 ripple phase when each lipid system
was taken below the gel-fluid transition. At 20C, the effect
of the peptide on the bilayer was moderately enhanced and
manifested by the presence of a mixture of fluid, gel, and
isotropic phases that likely were due to a broadening of
the lipid phase transition, as previously seen with related
peptides (9). A further reduction in temperature led to
complete destabilization of the DMPC bilayer by the native
peptide. The complete absence of a bilayer CSA and forma-
tion of isotropic 31P and 2H NMR spectra indicates that
small, rapidly tumbling lipid aggregates were formed in
a manner similar to that reported for magainin (19,20) and
reminiscent of the carpet model described by Shai (59,60).
Maculatin P15G and P15A had a less dramatic effect,
with the spectra affected by slower lipid motions due to
the reduced temperature. For the mixed DMPC/DMPG lipid
bilayers, additional disorder was seen in the form of small
isotropic peaks with both maculatin 1.1 and P15G, together
with a general reduction in motions for the bilayer phase forall three peptides. Although the membrane integrity was
significantly restored after this temperature transition, the
native peptide significantly perturbed the bilayer and a larger
isotropic component remained than was seen with either of
the two analogs, which suggests that the proline residue
causes a greater perturbance in the bilayer structure from
which it cannot readily recover even when the temperature
is restored to 30C.
Similar effects were previously observed for melittin,
which induces the formation of small 20- to 40-nm lipid
discs in phospholipid bilayers after passing through the
gel- to fluid-phase transition into the ripple and gel phase
(21,25). A reversible transition between disc-like micelles
and extended bilayers occurs with temperature through the
DMPC phase transition (23) and is driven by peptide inter-
action with defects formed in the gel and intermediate ripple
phases. Likewise, magainin 2 induces the formation of
isotropic 31P NMR signals in DMPC bilayers below the
phase transition (19). In a similar manner, sphingomyelin
and phosphatidylcholine bilayers were more effectively
solubilized by detergent in the gel phase, reflecting
a stronger interaction with the fluid phase (61). In this study,
both analogs caused a small increase in the order of the acyl
chain region nearer to the headgroup, with the P15A analog
increasing order even at the terminal methyl of the acyl
chain. This indicates that the absence of the proline residue
promoted an increased bilayer order akin to that observed
with melittin in phosphatidylcholine multilayers (32).
We also examined the effects of both fluid and gel-like
phases on maculatin 1.1-induced membrane changes by
DPI at 30C and 20C in terms of changes in the birefrin-
gence as a function of the mass of bound peptide. The results
obtained at 30C were also consistent with surface binding
of each peptide to the fluid DMPC at lower concentrations.
However, the overall birefringence-mass profile for macula-
tin 1.1 differed in shape compared with the profile for the
two analogs. For maculatin 1.1, there were large reversible
changes in birefringence at 5, 10, and 20 mM, which when
considered together with the presence of a significant
isotropic peak by NMR suggests that the decrease in bire-
fringence corresponds to the formation of toroidal-type
structures. Furthermore, this membrane structural change
was partially reversible, as evidenced by both the NMR
and DPI data. In contrast, the birefringence-mass profiles
for both maculatin P15G and P15A were curvilinear and
only partially reversible at the highest concentration.
Thus, in the presence of these two analogs, the fluid phase
of DMPC was initially more resistant to structural changes
until a threshold peptide concentration was reached, fol-
lowed by a sharp decline in membrane order, which only
partially recovered after dissociation of the peptide. In
contrast, the birefringence-mass profiles for all three
peptides with DMPC at 20C showed a linear decline re-
flecting a greater susceptibility of the more-rigid bilayer to
peptide disruption. Moreover, there was a greater decreaseBiophysical Journal 104(7) 1495–1507
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membrane order became more irreversible according to
maculatin 1.1 < P15G < P15A.
Previous studies showed significant interactions between
maculatin peptides and anionic model bilayers in the fluid
phase that are consistent with lipid domain formation for
the native peptide and the formation of highly disordered
structures akin to toroidal pores with the analogs
(5,9,11,13,15). In this study with mixed lipid bilayers,
DMPG enabled greater freedom of motion in the headgroup
region below the phase transition temperature comparedwith
the DMPC-only system. Moreover, the 2H spectrum was
consistent with gel-phase lipid acyl chains for each of the
peptides, indicating that the large 31P NMR peaks centered
about the isotropic chemical shifts were due to highly curved
lipid structures more in keeping with a toroidal pore rather
than formation of rapidly tumbling aggregates, as in the
carpet model, which additionally would also partially
average out the broader 2H spectra. Further reduction in
temperature led to additional disruption with an isotropic
component enriched in DMPC for the native peptide,
whereas the interaction with the maculatin P15G analog
was significantly enhanced with a large isotropic component
and no observable reduction in lipid motion at the low
temperature. The maculatin P15A analog exhibited slower
motions with a reduction in isotropic component, which
was likely due to highly disordered lipid rather than small
rapidly tumbling aggregates. In similarity to the DMPC
systems, raising the temperature back above the phase transi-
tion allowed the lamellar bilayer to reform, although it was
more perturbed relative to the starting condition, suggesting
that temperature cycling enhanced the peptide interaction.
The disordering of the DMPC/DMPG bilayer induced by
the maculatin peptides also showed distinctive inflection
points in the birefringence versus mass plot corresponding
to large decreases in birefringence without significant
changes in peptidemass. Similar inflection pointswere previ-
ously observed for the interaction of aurein with DMPC-con-
taining membranes at a particular L/P threshold (26).
However, in the case of aurein, the membrane structure
changes corresponded to membrane lysis. By comparison,
because we found no evidence of membrane lysis in this
study, the inflection points for the maculatin peptides are
likely to correspond to major membrane disordering, as evi-
denced by the isotropic peaks in the NMR spectra. Moreover,
as observed for DMPC, the curves were similar for each
peptide, but the inflection points occurred at increasingly
higher bound peptide mass, indicating that although all three
peptides act via a similar mechanism of bilayer disruption,
different levels of peptide are required to exert their effect.
AMPs generally form amphipathic a-helices in
membrane-like environments, which is essential for activity
(2) and interaction with bacterial membranes. We recently
demonstrated that maculatin 1.1, P15G, and P15A adopt
a helical structure in DMPC and DMPC/DMPG bilayersBiophysical Journal 104(7) 1495–1507(6). Replacing Pro in native maculatin with Ala (maculatin
P15A) skews the solution structure into a tighter, more
canonical a-helix that lacks the significant kink of the native
peptide and reorients the distribution of residues such that
the amphipathicity is altered (4,5,13) and an increase in
hemolytic activity occurs (6). However, the Pro-to-Ala
replacement resulted in a 5- to 10-fold decrease in antimi-
crobial activity (4). The ability of the peptide to change
conformation at the Pro residue, as seen for melittin
(29,32), the aM2 transmembrane segment of the nAChR
(37), and other AMPs (41,62) in lipid bilayers, may facili-
tate insertion. The results presented here, therefore, strongly
suggest that maculatin 1.1 is generally the most effective
peptide of the three analogs due to its kinked structure,
which can more easily perturb the bilayer structure than
the linear helical structures of maculatin P15G and P15A.
Moreover, the anionic bilayers are more susceptible to
peptide effects than the zwitterionic bilayer, predominantly
as a result of the lipid domains that form upon the binding
and insertion of the peptides.
A similar effect of proline on membrane interactions has
been observed for a number of peptides. For example, proline
analogs of peptides derived from the Helicobacter pylori
ribosomal protein L1 (HPA) were studied by surface plas-
mon resonance and DPI (35). The kink induced by proline
was shown to disrupt the hydrophobic membrane binding
and insertion face, which led to a lower amount binding to
the membrane. The profiles of birefringence changes for
maculatin peptides as a function ofmembrane-bound peptide
mass more closely resembled the profiles obtained for the
HPA peptides inserting into the bilayer. However, maculatin
peptides induced a smaller degree of disordering as a function
of peptide mass than the HPA peptides.Model of maculatin membrane disruption
Based on these studies, we propose a model for the mecha-
nism of action for maculatin-related peptides that centers
on the effect of the kinked helical structure of maculatin
1.1. The NMR data indicate that maculatin 1.1 binds
predominantly at the surface regions of the bilayer, whereas
both the NMR and DPI results indicate that this binding
causes a drop in the bilayer order. Maculatin 1.1 is strongly
amphipathic along both ends of the helix, and to allow
maximal interaction with the membrane surface, the peptide
may cause the bilayer surface to indent to accommodate the
kink and maximize the interaction with the entire peptide as
shown schematically in Fig. 6. This surface imperfection/
indentation then facilitates subsequent partial insertion of
the peptide into the bilayer. According to the DPI and
NMR results, this subsequent insertion was associated with
a drop in the bilayer order after a certain level of bound
peptidewas achieved, although this drop in order was largely
reversible in DMPC. The flexibility of the acyl chains plays
an important role in the ability of themembrane to respond to
FIGURE 6 Schematic illustration depicting
membrane bilayer structural changes upon the
interaction of 20 mM maculatin 1.1 and P15A.
Before peptide binding occurs, the gel phase is
a thicker, more rigid bilayer. Upon peptide binding,
changes in the lipid structure occur during initial
peptide surface binding with minimal penetration
of the bilayer interior. As the concentration
increases, the initial surface binding is associated
with partial insertion and disruption of membrane
order facilitated by the kinked helical structure of maculatin 1.1. Subsequent steps involve partial insertion into the membrane, until an effective concentra-
tion of peptide accumulates followed by a rapid decrease in birefringence without further increase in mass, which indicates peptide organization on the
surface before major bilayer disruption that may approximate a toroidal-like structure (63). Peptide dissociation and birefringence recovery follows, indi-
cating removal of excess peptide and bilayer reordering to accommodate the inserted peptide. Overall, the threshold bound peptide concentration required
to cause a large change in bilayer order is lower for maculatin 1.1 than for either of the two analogs due to the effect of the kink structure, which facilitates
surface indentation and phospholipid disorder. In addition, the lower-temperature phase is more susceptible to peptide-induced disordering.
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membrane order, indicating that below the main transition
temperature, the more-rigid intermediate phase has less
capacity to absorb the peptide’s impact on the lipid order.
In the presence of DMPG, there was a greater propensity
for the isotropic phase to exist, because the membrane was
more susceptible to the disrupting effects of peptide binding,
corresponding to the sharp but still reversible changes in
membrane order at lower peptide levels than observed
with DMPC. This reversibility was also observed for both
the fluid and gel phases for each peptide, but the inflection
point occurred at a higher peptide mass for the lower-
temperature phase.
The influence of the Pro residue and the effect of the kink
on disruption of the bilayer were clearly evident from the
behavior of maculatin P15G and P15A. Maculatin P15G is
more flexible than maculatin 1.1 but is likely to adopt
some degree of kink structure given the flexibility of the
Gly residue. Thus, when P15G approaches and binds to
the membrane, the degree of indentation is less prominent
and hence subsequent insertion is not as readily achievable.
As a consequence, a higher amount of peptide is required to
exert a disruptive effect. This effect was even more evident
for P15A, which contains an Ala residue that is less flexible
than Gly, is likely to adopt a relatively linear helical confor-
mation, and is also more hydrophobic. This peptide bound
more strongly than maculatin 1.1 or P15G, and the impact
on bilayer structure again occurred at a higher concentra-
tion. Thus, at a given peptide concentration, the overall
impact of the peptide can be evaluated in terms of the ability
of the bilayer to recover from the bilayer changes induced
by the binding and insertion of the peptide. Therefore, the
reversibility of the changes in membrane structural integrity
is a critical component of AMP action and can be measured
in real time.CONCLUSIONS
It is well accepted that cytolytic peptides act by disrupting
the membrane bilayer structure in an irreversible manner.The challenge then is to understand the precise bilayer struc-
tural changes that occur before this final disruption. Such
information would provide important criteria for designing
peptides that can exert minor or reversible effects on
mammalian cells but disrupt microbial membranes in an
irreversible manner. The overall aim of this study was to
investigate the role of proline in AMP structure and activity.
We used solid-state NMR and DPI to obtain new (to our
knowledge) insight into the structural changes in phospho-
lipid bilayers induced by maculatin 1.1, and to provide
a rationale for its generally higher potency relative to other
analogs. The mode of action of AMPs can now be described
in terms of the effects on membrane structure and lipid
dynamics before, during, and after their interaction. Based
on these studies, we propose a model for the mechanism
of action for maculatin-related peptides that centers around
the effect of the kinked helical structure of maculatin 1.1 on
bilayer structure. The overall process is the same for the
three peptides and both lipid systems, i.e., the molecular
organization is essentially the same from the start of binding
to the end of dissociation, but the process of going from the
beginning to the end is different. The peptide kink structure
facilitates the disruption after a threshold peptide level is
reached, at which point the membrane integrity is either
compromised or able to recover. This result has significant
implications for the design of potent and selective AMPs.SUPPORTING MATERIAL
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